Search Results 1421-1430 of 18379 for Immunode
D., is a hematologist and assistant professor of medicine at Mayo Clinic, Rochester, Minnesota. He recieved his Ph.D. in organic chemistry from The Scripps ...
History of clinically significant liver disease, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or tuberculosis infection. Previously ...
Patients with human immunodeficiency virus (HIV) are eligible with the following: On stable regimen of anti-retroviral therapy (highly active anti ...
No ongoing requirement for dexamethasone or anti-epileptic drugs. Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy are ...
Patients who are known to be positive for human immunodeficiency virus (HIV) are eligible only if they have all of the following: A stable regimen of highly ...
... immunodeficiency that, in the investigator's opinion, would compromise the safety of the participant, interfere with the interpretation of the study results ...
The participant has a positive test result for hepatitis B surface antigen, hepatitis C virus (HCV), human immunodeficiency virus (HIV) antibody/antigen at ...
Any form of primary immunodeficiency. Active immune-mediated disease requiring systemic steroids or other immunosuppressive treatment (except if related to ...
Known positive testing for human immunodeficiency virus or history of acquired immune deficiency syndrome; Known hypersensitivity to recombinant proteins ...
Patients with human immunodeficiency virus (HIV) infection may be eligible provided they meet the following criteria: CD4-positive cell count >= lower limit ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.